News
Melbourne scientists are teasing out how the "Hippo pathway" works at the molecular level, improving understanding of how it ...
LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing ...
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which ...
In a recent landmark study, scientists have unveiled how HIV-1 penetrates the cell's nuclear barrier—a discovery that could reshape antiviral strategies. The research, led by Professor Peijun Zhang, ...
A team at Scripps Research has created a microchip that can rapidly reveal how a person's antibodies respond to viruses using only a drop of blood. This game-changing technology, called mEM, condenses ...
A new microchip invented by Scripps Research scientists can reveal how a person’s antibodies interact with viruses—using just a drop of blood. The technology offers researchers faster, clearer ...
The Trump administration has lifted a freeze on federal funds for HIV prevention and surveillance programs, officials said, following an outcry from HIV prevention organizations, health experts ...
MIT's new dual-adjuvant vaccine offers strong HIV protection with a single dose, potentially aiding in the fight against challenging viruses.
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an antiviral drug for HIV prevention based on his findings.
Here’s what everyone should know about this new HIV prevention shot Yeztugo, a twice-a-year shot approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year ...
A newly approved medication to prevent HIV infection that can be injected twice a year is being hailed as a breakthrough in the fight against HIV/AIDS. “It is a wonder drug,” said Rama Rao ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results